After fight over cancer clinicians, Dana-Farber and Brigham are playing nice again
In a joint communication recently distributed to the thousands of clinicians and support staff who...
In a joint communication recently distributed to the thousands of clinicians and support staff who...
The landscape of American healthcare is currently undergoing a period of profound transformation, marked by...
The Phase 3 results focus on the reduction of proteinuria—the presence of excess proteins in...
However, while the headlines are dominated by the glamour of weight-loss breakthroughs, a much grittier...
The announcement came late on a Friday evening, the traditional hour for news that an...
The atmosphere during the Food and Drug Administration’s media call this past Thursday was not...
After reviewing data for active pharmaceutical ingredients (API) from the past two years, the researchers...
The abrupt cancellation of the first scheduled meeting of the Interagency Autism Coordinating Committee (IACC)...
Prasad’s tenure has been nothing short of transformative, albeit deeply divisive. As the head of...
The executive revolving door in the biotechnology sector continues to spin at a dizzying pace,...